default author photo

Christina Kotsi

Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG

45 Sidney Street

2nd Floor

Cambridge, MA 02139

United States

  • Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Development of an Updated, Standardized, Patient-Centered Outcome Set for Lung Cancer

Number of pages: 27 Posted: 12 Jul 2022
Belle H. de Rooij, Corina van den Hurk, Veerle Smaardijk, Paz Fernandez-Ortega, Arturo Navarro-Martin, Lidia Barberio, Matthias Guckenberger, Severin Schmid, Iris Walraven, Susan Vallow, Christina Kotsi, Matthias Preusser, Erika Mosor, Jente M. Klok, Annemarie Becker, Alessandra Milani, Lyudmil Ninov and Lonneke V. van de Poll-Franse
Netherlands Comprehensive Cancer Organisation - Department of Research and Development, Netherlands Comprehensive Cancer Organisation - Department of Research and Development, Netherlands Comprehensive Cancer Organisation - Department of Research and Development, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Patients organization Longkanker Nederland, University Hospital Zurich - Department of Radiation Oncology, University of Freiburg - Medical Center, Radboud University Nijmegen - Radboud University Medical Center, Novartis Pharmaceuticals Corporation, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Medical University of Vienna, Medical University of Vienna, Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, Amsterdam Academic Medical Center, European Institute of Oncology (IEO) IRCCS, European Patients’ Forum and Netherlands Comprehensive Cancer Organisation - Department of Research and Development
Downloads 49 (1,074,648)
Citation 1

Abstract:

Loading...

lung cancer, core outcome set, patient-reported outcomes, quality of life, value-based healthcare